CY1509A - Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin - Google Patents

Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin Download PDF

Info

Publication number
CY1509A
CY1509A CY1509A CY150983A CY1509A CY 1509 A CY1509 A CY 1509A CY 1509 A CY1509 A CY 1509A CY 150983 A CY150983 A CY 150983A CY 1509 A CY1509 A CY 1509A
Authority
CY
Cyprus
Prior art keywords
component
composition according
molecular weight
present
pharmaceuticaily acceptable
Prior art date
Application number
CY1509A
Other languages
English (en)
Inventor
Hans Buhlmann
Dieter Welzel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CY1509A publication Critical patent/CY1509A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY1509A 1982-12-10 1983-12-07 Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin CY1509A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3245695 1982-12-10

Publications (1)

Publication Number Publication Date
CY1509A true CY1509A (en) 1990-08-03

Family

ID=6180290

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1509A CY1509A (en) 1982-12-10 1983-12-07 Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin

Country Status (25)

Country Link
JP (1) JPH0672101B2 (OSRAM)
AT (1) AT382514B (OSRAM)
AU (1) AU570658B2 (OSRAM)
BE (1) BE898356A (OSRAM)
CA (1) CA1224416A (OSRAM)
CH (1) CH656533A5 (OSRAM)
CY (1) CY1509A (OSRAM)
DD (1) DD215469B3 (OSRAM)
DK (1) DK162475C (OSRAM)
FR (1) FR2537435B1 (OSRAM)
GB (1) GB2131691B (OSRAM)
GR (1) GR79745B (OSRAM)
HK (1) HK23290A (OSRAM)
HU (1) HU190513B (OSRAM)
IE (1) IE56366B1 (OSRAM)
IL (1) IL70406A (OSRAM)
IT (1) IT1172368B (OSRAM)
LU (1) LU85127A1 (OSRAM)
NL (1) NL8304221A (OSRAM)
NZ (1) NZ206523A (OSRAM)
PH (1) PH23451A (OSRAM)
PT (1) PT77803B (OSRAM)
SE (1) SE468973B (OSRAM)
SG (1) SG53989G (OSRAM)
ZA (1) ZA839200B (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432661A1 (de) * 1984-09-05 1986-03-06 Albert Prof. Dr. 6907 Nußloch Landsberger Carcinom-therapeutikum
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1245761B (it) * 1991-01-30 1994-10-14 Alfa Wassermann Spa Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2554533C3 (de) * 1975-12-04 1984-08-30 Sandoz-Patent-Gmbh, 7850 Loerrach Verwendung von Dihydroergotamin und Heparin
DE2809618A1 (de) * 1978-03-06 1979-09-20 Sandoz Ag Neues therapeutisches praeparat und verfahren zu dessen herstellung
SE441142B (sv) * 1975-12-04 1985-09-16 Sandoz Ag Forfarande for framstellning av ett terapeutiskt preparat med antitrombotiska egenskaper
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
DE2945636A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Stabile loesungen von hydrierten ergotalkaloiden bzw. ihren salzen und heparin bzw. seinen salzen sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
GR79745B (OSRAM) 1984-10-31
IT8349456A0 (it) 1983-12-07
SG53989G (en) 1989-12-29
JPS59116222A (ja) 1984-07-05
DK162475C (da) 1992-05-11
GB2131691B (en) 1986-12-03
SE468973B (sv) 1993-04-26
NL8304221A (nl) 1984-07-02
DK162475B (da) 1991-11-04
NZ206523A (en) 1987-04-30
PH23451A (en) 1989-08-07
IT8349456A1 (it) 1985-06-07
BE898356A (fr) 1984-06-04
FR2537435A1 (fr) 1984-06-15
DK565783D0 (da) 1983-12-08
CH656533A5 (de) 1986-07-15
FR2537435B1 (fr) 1987-03-20
HK23290A (en) 1990-04-06
PT77803A (en) 1984-01-01
IT1172368B (it) 1987-06-18
DK565783A (da) 1984-06-11
IL70406A0 (en) 1984-03-30
DD215469B3 (de) 1988-03-09
DD215469A5 (de) 1984-11-14
SE8306792D0 (sv) 1983-12-08
HUT34124A (en) 1985-02-28
IE832896L (en) 1984-06-10
IE56366B1 (en) 1991-07-03
GB8332653D0 (en) 1984-01-11
JPH0672101B2 (ja) 1994-09-14
ZA839200B (en) 1985-07-31
IL70406A (en) 1988-08-31
LU85127A1 (fr) 1984-10-22
PT77803B (en) 1986-04-17
SE8306792L (sv) 1984-06-11
AU570658B2 (en) 1988-03-24
HU190513B (en) 1986-09-29
GB2131691A (en) 1984-06-27
AT382514B (de) 1987-03-10
CA1224416A (en) 1987-07-21
ATA428483A (de) 1986-08-15
AU2222183A (en) 1984-06-14

Similar Documents

Publication Publication Date Title
US6224857B1 (en) Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics
EP0193287B1 (en) Etoposide preparations
US4777161A (en) Medicaments favoring the properties of blood flow and their use in therapeutics
CY1800A (en) Piroxicam solutions of increased stability without tissue-damaging effect
EP0233615B1 (en) Aqueous preparation and method of preparation thereof
CY1509A (en) Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin
DE69518706T2 (de) Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom
EP0277462A1 (de) Verfahren zur Herstellung nasaler Lösungen enthaltend synthetisches Human calcitonin.
IE48254B1 (en) Stabilized aqueous parenteral antibiotic compositions and a process for their preparation
US5561154A (en) Treatment of acute urinary retention
NZ212097A (en) Parenteral pharmaceutical composition comprising metoclopramide (4-amino-5-chloro-n-((2-diethylamino) ethyl)-2-methoxybenzamide) and optionally sodium metabisulphite
CA1165692A (en) Stable solutions of hydrogenated ergot alkaloids
CN114364401A (zh) 防止含有对二羟硼基苯丙氨酸的注射液剂的析出的方法
US5081153A (en) Sterile parenteral composition
JPH0366617A (ja) 静脈内投与用フエニトインナトリウム製剤
DE3701461C2 (OSRAM)
JP2946015B2 (ja) 安定な抗ウィルス点滴用注射剤
AU614589B2 (en) Antiarteriosclerotic agent
KR900002745B1 (ko) 안정 주사용 진토제 조성물의 제조방법
HK40063208A (en) Method for preventing precipitation of injectable solution containing p-boronophenylalanine
KR100738021B1 (ko) 은행엽 엑스 고농도 함유 주사제
DE3343818C2 (OSRAM)
KR830000526B1 (ko) 에토 미데이트를 함유한 주사제의 제조방법
JPH05262650A (ja) 安定な注射用組成物
GB2337202A (en) Use of cyanines,isocyaninines and pseudoisocyanines as diuretics